SeraCare Buys DNA Startup

Oceanside-based SeraCare Life Sciences ( has purchased Genomics Collaborative Inc for $16M. GCI focuses on provoding clinical samples and the application of human genetics to target validation for drug discovery. SeraCare is a manufacturer and provider of biological materials and services essential for the manufacture of diagnostic tests, commercial bioproduction of therapeutic drugs.